release date, page-27

Nathan.

On the revenue side of the company as you mention I am happy to see a continued sales that alleviate the need for constant capital raisings. I am sure we are all past those.

As for pushing the thermalife via ACA etc, I am not 100% sure whether this is the best angle. As keen as we all are for exposure I am sure a more repretable marketing campaign, and I am sure this is where crossmark comes in for sure that targets the markets, the reps, who are really the people who push the product onto the consumers.

I am sure once it is on the shelves as a viable and better alternative to vultaren it should adopt its own market share. This however may take several years, and hopefully the funds can be used to develop even more productive products.

Ok.. bring on the consistent 2cents, piss off the day traders and the captial raisings, the only thing we should be raising is champagne, and hopefully without sore joints via extravegant usage of thermalife.

Cheers
SC